The 42nd Annual CFS: Innovative Cancer Therapy for Tomorrow covers topics such as:
- Harnessing the Latest Technologies, Biomarkers, and Tests to Optimize Clinical Decision Making
- Immunotherapies and Their Latest Applications in Cancer
- Expanded Applications of Precision Medicine
- Pan-Tumor Testing to Guide Treatment Planning
- Chemotherapy Versus Modern Agents: How to Get the Most Out of Available Therapies
- Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy
- Does Chemotherapy Improve Outcomes in Early-Stage High-Risk Uterine Cancer?
- Focused Update on Rare Hematologic Malignancies: Waldenström Macroglobulinemia and Blastic Plasmacytoid Dendritic Cell Neoplasm
- Evolving Treatment Paradigms in Lung Cancer: New Agents, New Indications, New Assays
- State-of-the-Art Care for Patients With Melanoma: Sequencing, Triplet Combinations, Adjuvant Therapy, and Immunotherapy Selection
- PARP Inhibitor-Based Therapy for Breast and Gynecologic Cancers
- Targeted and immunotherapeutic strategies for RCC and Bladder Cancer
- Evidence-Based Management Updates Across All Breast Cancer Subtypes
- Fertility Preservation in Premenopausal Women With Breast Cancer
- Improving Outcomes Through Optimized Adverse Event Management
- Who Should Receive Extended Adjuvant Hormone Therapy for Breast Cancer?
- Updates in Glioblastoma Multiforme; Head, Neck, and Thyroid Cancers; and Sarcoma
- New Agents, New Opportunities, and New Clinical Questions in Gastrointestinal Cancers
- Back by Popular Demand: Nursing and How I Do It tracks and Medical Crossfire® debates
- 2018 Special Focus: Patient-Centered Care and Oncology Practice: CINV, Pain Management, Neutropenia, Direct-to-Consumer Testing, and Next-Generation Sequencing
- And Much More!
The 42nd Annual CFS: Innovative Cancer Therapy for Tomorrow might be held in New York City in Nov 2024.
